• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Revolutions Medical Announces Plans to Move Forward With Strategic Product Development To Test and Evaluate Its New Breakthrough MRI Software Technology

Posted on: Tuesday, 11 September 2007, 09:00 CDT

Revolutions Medical Corporation (PINK SHEETS: RMCP) today announced that the Company is presently moving forward with Strategic Product Development of Lexington, MA to integrate, test and evaluate applications for its MRI imaging software technology acquired in the Clear Image Acquisition transaction earlier this year. It is expected that the first series of testing will take place both domestically and internationally and will last approximately 120 days.

"This recent acquisition presents Revolutions Medical with a tremendous opportunity to prove and test applications for our unique automatic segmentation product while allowing us to present and demonstrate our products to the industry at upcoming trade shows such as the RSNA show in November. Further, this new technology will provide a platform for building on our other patents and products. We expect to continue extensive testing as we go forward and build long term relationships with the MRI and PACS providers worldwide," stated Ron Wheet, CEO of Revolutions Medical Corp.

About Revolutions Medical Corporation

Revolutions Medical Corporation is committed to continually developing and distributing new products and tools to the medical industry, whether internally or through acquisitions. Its goals are to make health care safer and less expensive by reducing risks and cutting time and expenses. Its products include the RevVac safety syringe, safety blood drawing device and safety IV catheter. The world market for safety-engineered medical devices (SEMDs) is projected to exceed 2 billion this year and is forecasted to maintain a 20% annual growth rate in the near term. Revolutions Medical also provides software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software includes sorting of images, color, 3D, and automatic segmentation of images. These tools will enhance the physician's diagnostic confidence in an industry that is growing at 10% - 15% (more than 25 million procedures) per year with a worldwide market potential for these tools that exceed $3.5 billion.

Safe Harbor

Forward-looking statements made in this release are made pursuant to the "safe-harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Revolutions Medical Corporation are not a guarantee of future performance. This news release includes forward-looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty.

Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Revolutions Medical Corporation, and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.

Source: Business Wire

More News in this Category